Kelly Schick

Insider Reports History

Location
Waltham, MA
Signature
/s/ Shagha Russell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kelly Schick:

Company Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief People Officer Common Stock 108,885 $346,254 $3.18 14 Feb 2025 Direct
C4 Therapeutics, Inc. Chief People Officer Performance Restricted Stock Units 10,500 $63,420 $6.04 07 Nov 2024 Direct
C4 Therapeutics, Inc. Chief People Officer Stock Option (Right to Buy) 84,700 14 Feb 2025 Direct

Insider Reports Filed by Kelly Schick

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CCCC C4 Therapeutics, Inc. 13 Feb 2025 4 -$13,082 4 Chief People Officer 18 Feb 2025, 16:54
CCCC C4 Therapeutics, Inc. 07 Nov 2024 3 -$6,656 4 Chief People Officer 12 Nov 2024, 16:17
CCCC C4 Therapeutics, Inc. 16 Sep 2024 3 -$4,204 4 Chief People Officer 17 Sep 2024, 17:12
CCCC C4 Therapeutics, Inc. 07 Mar 2024 4 $0 4 Chief People Officer 08 Mar 2024, 19:24
CCCC C4 Therapeutics, Inc. 13 Feb 2024 3 -$11,330 4 Chief People Officer 15 Feb 2024, 17:05
CCCC C4 Therapeutics, Inc. 18 Sep 2023 1 $0 4 Chief People Officer 19 Sep 2023, 20:23
CCCC C4 Therapeutics, Inc. 30 Aug 2023 3 -$1,937 4 Chief People Officer 31 Aug 2023, 17:10
CCCC C4 Therapeutics, Inc. 13 Feb 2023 2 $0 4 Chief People Officer 15 Feb 2023, 15:45
CCCC C4 Therapeutics, Inc. 30 Jan 2023 3 -$10,122 4 Chief People Officer 01 Feb 2023, 15:09
CCCC C4 Therapeutics, Inc. 26 May 2022 1 -$7,725 4/A Chief People Officer 14 Jun 2022, 16:45
CCCC C4 Therapeutics, Inc. 25 May 2022 2 $0 4 Chief People Officer 27 May 2022, 16:16
CCCC C4 Therapeutics, Inc. 16 Mar 2022 0 $0 3 Chief People Officer 17 Mar 2022, 16:19